Table 2.
Related pathways of transcriptomics detected in BJF-treated rats lung tissue.
Term | Count | % | p value |
---|---|---|---|
Ribosome | 29 | 0.174751 | 6.30E − 12 |
Aminoacyl-tRNA biosynthesis | 11 | 0.066285 | 7.15E − 04 |
Endocytosis | 30 | 0.180777 | 7.19E − 04 |
Prostate cancer | 17 | 0.10244 | 0.001294 |
Renal cell carcinoma | 14 | 0.084363 | 0.002109 |
Ubiquitin mediated proteolysis | 20 | 0.120518 | 0.00352 |
Neurotrophin signaling pathway | 20 | 0.120518 | 0.00352 |
Adherens junction | 14 | 0.084363 | 0.004004 |
Tight junction | 20 | 0.120518 | 0.005003 |
Citrate cycle (TCA cycle) | 8 | 0.048207 | 0.006777 |
MAPK signaling pathway | 32 | 0.192829 | 0.013297 |
Proteasome | 10 | 0.060259 | 0.013316 |
Nucleotide excision repair | 9 | 0.054233 | 0.015824 |
N-Glycan biosynthesis | 9 | 0.054233 | 0.018075 |
Spliceosome | 17 | 0.10244 | 0.023539 |
Oxidative phosphorylation | 18 | 0.108466 | 0.03465 |
Antigen processing and presentation | 13 | 0.078337 | 0.037581 |
Propanoate metabolism | 7 | 0.042181 | 0.038533 |
Endometrial cancer | 9 | 0.054233 | 0.040556 |
Amino sugar and nucleotide sugar metabolism | 8 | 0.048207 | 0.045144 |